As shown in Figure 8, all compounds significantly reduced the levels of XIAP and survivin expression, suggesting that compounds 1–3, particularly compound 3, may inhibit the XIAP and survivin expression, contributing to their apoptosis-inducing activity in NSCLC cells. This evidence concerns the gene XIAP and non-small cell lung carcinoma.